Announced Wed, 17 Jun · 13:32 IST
Vivimed Labs under insolvency, invites resolution bids
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.4%1-day move
₹6.21
prior close
₹6.19
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.6-1.5-3.9-2.4-5.0-5.0-5.0-5.5-3.5-10.6-15.6——
Up moveDown movePending
AI summary
Vivimed Labs has entered Corporate Insolvency Resolution Process. Form G has been published inviting Expression of Interest from potential resolution applicants. The pharma firm has manufacturing units in Hyderabad, Haridwar, Kashipur, and Bidar with 352 employees. Revenue was 103.60 Cr in FY25 and 48.23 Cr for nine months ended Dec 2025. Last date for bids is June 29, 2026, and resolution plans are due by August 28, 2026.
Likely market impact
Existing shareholders likely to face significant dilution or value loss depending on the resolution plan approved under IBC.